Related Experiment Video
Updated: May 4, 2026

Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats
Published on: August 1, 2018
Is it tea time for portal hypertension?
Jordi Gracia-Sancho1, Jaime Bosch1
1*Barcelona Hepatic Hemodynamic Laboratory, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clinic de Barcelona, Barcelona, Spain and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), University of Barcelona, Barcelona, Spain.
Insights
Green tea polyphenols (GTPs) show promise in treating liver cirrhosis complications. Long-term GTPs intake reduced portal hypertension by decreasing liver resistance and hyperdynamic circulation, potentially via inhibiting blood vessel growth.
Area of Science:
- Hepatology
- Gastroenterology
- Pharmacology
Background:
- Portal hypertension is a major complication of liver cirrhosis and a leading cause of mortality in chronic liver disease.
- Effective treatments must address elevated hepatic resistance and hyperdynamic circulation, the core mechanisms of portal hypertension.
Purpose of the Study:
- To investigate the therapeutic effects of green tea polyphenols (GTPs) on portal hypertension in the context of liver cirrhosis.
- To elucidate the underlying mechanisms by which GTPs may ameliorate portal hypertension.
Main Methods:
- Long-term administration of GTPs to a model of cirrhosis and portal hypertension.
- Assessment of hepatic resistance and splanchnic hyperdynamic circulation.
- Evaluation of splanchnic angiogenesis as a potential mechanism.
Main Results:
- Long-term GTPs administration inhibited the development of cirrhosis and portal hypertension.
- GTPs significantly decreased both hepatic resistance and splanchnic hyperdynamic circulation.
- The beneficial effects of GTPs were associated with down-regulation of splanchnic angiogenesis.
Conclusions:
- Green tea polyphenols demonstrate a beneficial effect in improving portal hypertension associated with liver cirrhosis.
- GTPs may act by reducing hepatic resistance, splanchnic hyperdynamic circulation, and inhibiting angiogenesis.
- Natural compounds like GTPs offer potential as a nutraceutical approach for managing cirrhosis patients.
Abstract:
Portal hypertension is the main complication of cirrhosis and represents a leading cause of death in patients with chronic liver disease. Therapeutic agents to improve portal hypertension should ameliorate the underlying mechanisms of portal hypertension: the elevated hepatic resistance and the hyperdynamic circulation. In the present issue of Clinical Science, Hsu and co-workers show the beneficial effects of GTPs (green tea polyphenols) in improving portal hypertension. Long-term administration of GTPs inhibited the development of cirrhosis and portal hypertension by decreasing both hepatic resistance and splanchnic hyperdynamic circulation. The main underlying mechanism of the benefits of GTPs appears related to the down-regulation of splanchnic angiogenesis. The present study adds further evidence supporting the potential of natural compounds for an effective nutriceutical approach to the treatment of patients with cirrhosis of the liver.
More Related Videos
Related Concept Videos
Portal Hypertension
Esophageal Varices-I: Introduction
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Hepatic Encephalopathy
Hepatic Portal System
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
Angle Closure Glaucoma: Treatment

